Close
KaloCyte
  • MISSION
  • ABOUT
  • TEAM
  • ERYTHROMER
  • NEWS & EVENTS
  • CAREERS
  • CONTACT
Select Page

Capital Efficient Scale-Up

Jul 3, 2024

  • Featured in Science: The ultimate blood substitute? The U.S. military is betting $46 million on it / Science / AAAS
  • Raised additional $0.7M of bridge round
  • Team expanded to 10 employees, plus one intern
  • Awarded DoD CMRP TTDA grant ($2.5M) for lyophilization optimization
  • Subcontract for DARPA FSHARP expanded by $500K
  • Maryland Tech Council ICON Awards finalist – Emerging Life Science CEO of the Year
  • Qualified Maryland Biotech Company (QMBC) for State Biotech Investment Initiative Tax Credit (BIITC)
©2026 KaloCyte, Inc. | Privacy Policy | Terms of Use